Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese <it>db/db</it> mice

<p>Abstract</p> <p>Background</p> <p>Telmisartan is a well-established angiotensin II type 1 receptor blocker that improves insulin sensitivity in animal models of obesity and insulin resistance, as well as in humans. Telmisartan has been reported to function as a parti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Shiota Asuka, Shimabukuro Michio, Fukuda Daiju, Soeki Takeshi, Sato Hiromi, Uematsu Etsuko, Hirata Yoichiro, Kurobe Hirotsugu, Maeda Norikazu, Sakaue Hiroshi, Masuzaki Hiroaki, Shimomura Iichiro, Sata Masataka
Format: Artigo
Jezik:Inglês
Izdano: BMC 2012-11-01
Serija:Cardiovascular Diabetology
Teme:
Adiponectin
AMP-activated protein kinase
Obesity
Peroxisome proliferator-activated receptor-γ
SIRT1
Online dostop:http://www.cardiab.com/content/11/1/139
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki